Concepedia
Statistics
Publications
29
Citations
1.5K
H-Index
20
Active since
2012
Affiliations
AbbVie (United States)(Current)
Peter MacCallum Cancer Centre
Dana-Farber Cancer Institute
Northwestern University
The Royal Melbourne Hospital
Wijith Munasinghe is an author at AbbVie (United States) specializing in medicine, pharmacology, and cancer pharmacology.
Publications per year
2012–2023
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
John F. Seymour, Shuo Ma, Danielle M. Brander et al. · The Lancet Oncology · 2017 · 327 citations
Life Sciences, Hematology, Immunology +11
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
Philippe Moreau, Asher Chanan‐Khan, Andrew W. Roberts et al. · Blood · 2017 · 271 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +12
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma
David A. Reardon, Andrew B. Lassman, Martin J. van den Bent et al. · Neuro-Oncology · 2016 · 112 citations · Full text
Medicine, Oncology, Pharmacology +17
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Luciano J. Costa, Faith E. Davies, Gregory Monohan et al. · Blood Advances · 2021 · 87 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma
Hui Gan, David A. Reardon, Andrew B. Lassman et al. · Neuro-Oncology · 2017 · 78 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 29